By Sabela Ojea
The Oncology Institute is buying back 2 million shares of its common stock, the company said in a Securities and Exchange Commission filing Wednesday.
Its board of directors approved the share-repurchase program Monday.
The institute didn't provide details on what motivated it to repurchase the stock.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
08-30-23 1611ET